APA (7th ed.) Citation

Chau, I., Fakih, M., García-Alfonso, P., Linke, Z., Ruiz Casado, A., Marques, E. P., . . . Cartwright, T. (2020). Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study. Cancers, 12(3), 657. https://doi.org/10.3390/cancers12030657

Chicago Style (17th ed.) Citation

Chau, Ian, Marwan Fakih, Pilar García-Alfonso, Zdenĕk Linke, Ana Ruiz Casado, Eduardo Polo Marques, Pascaline Picard, Marina Celanovic, and Thomas Cartwright. "Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study." Cancers 12, no. 3 (2020): 657. https://doi.org/10.3390/cancers12030657.

MLA (9th ed.) Citation

Chau, Ian, et al. "Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study." Cancers, vol. 12, no. 3, 2020, p. 657, https://doi.org/10.3390/cancers12030657.